Status:
UNKNOWN
Analysis of a New Biomarker for Prostate Cancer Diagnosis
Lead Sponsor:
Corporacion Parc Tauli
Conditions:
Patients With Suspected Prostate Cancer
Eligibility:
MALE
45-75 years
Brief Summary
The aim of our study is to determine if the levels of the "HEM" substance in seminal plasma are associated with the presence of prostate cancer in transrectal prostate biopsy.
Eligibility Criteria
Inclusion
- Clinical or laboratory suspected of prostate cancer
Exclusion
- Inability to ejaculate
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT01819740
Start Date
April 1 2013
Last Update
March 28 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Parc Taulí
Sabadell, Barcelona, Spain, 08208